Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | FABP4 | P15090 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | POLB | P06746 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14212746 | 0.93 | MYC (0.34) | MYCGAAHTTCYP1A2CYP3A4 | |
| SCHEMBL16489111 | 0.93 | MYC (0.34) | MYCGAAHTTCYP1A2CYP3A4 | |
| SCHEMBL14870371 | 0.84 | GAA (0.34) | MYCGAAHTTCYP1A2CYP3A4 | |
| SCHEMBL25266487 | 0.84 | MYC (0.34) | MYCGAAHTTCYP1A2CYP3A4 | |
| SCHEMBL14681719 | 0.83 | LMNA (0.35) | GAACYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL21309436 | 0.82 | ALDH1A1 (0.35) | HTTCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL17988281 | 0.78 | — | — | |
| SCHEMBL12302213 | 0.75 | TSHR (0.36) | GAACYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL16272870 | 0.75 | HTT (0.34) | GAAHTTCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL12434027 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11655504-B2 | High intensity labeled reactant compositions and methods for sequencing | Quantum-Si Incorporated (US) | 2023-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11655504-B2 | High intensity labeled reactant compositions and methods for sequencing | NSUN2, FBL, DNMT3A | MYC 529/4885GAA 2750/4885HTT 473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.